Nickel, J. C. (2023) “MV140 sublingual vaccine reduces recurrent urinary tract infection in women: Results from the first North American clinical experience study”, Canadian Urological Association Journal, 18(2), pp. 25–31. doi: 10.5489/cuaj.8455.